Regulatory edge Ceevra holds FDA clearance and CE Mark for all surgeries and leads in ML-generated 3D images for urologic and thoracic planning, signaling strong compliance and a compelling case to engage hospital systems and surgical centers seeking validated, regulated visualization solutions.

Clinical impact With adoption in over 5,000 operations and potential to save organs, shorten hospital stays, and reduce cancer recurrence risk, position the solution as a value driver for surgeons, oncologists, and perioperative teams aiming to improve outcomes and efficiency.

SMB enterprise fit Company size and revenue positioning suggest a primary target focus on mid-market health tech adopters and specialty hospitals; emphasize scalable deployment, training, and support options that align with slower, budget-conscious procurement cycles common in these segments.

Tech and security Leverage ISO 13485 certification and cloud infrastructure (AWS, DigitalOcean) to address strict data governance, interoperability, and security requirements; tailor conversations around HIPAA/regulated data handling and integration with existing imaging workflows.

Growth signals Funding and modest revenue indicate a growth phase with potential buyer interest from larger health systems and education platforms; explore partnerships with surgical education providers, medical device groups, and enterprise training platforms to expand reach and cross-sell opportunities.